Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. European Lung Cancer Congress 2024

Novocure GmbH - Tumor treating fields therapy: A force for change in lung cancer

Welcome and introduction

Date

20 Mar 2024

Session

Novocure GmbH - Tumor treating fields therapy: A force for change in lung cancer

Topics

Cancer Biology;  Tumour Immunology;  Immunotherapy

Tumour Site

Non-Small Cell Lung Cancer;  Mesothelioma

Presenters

Maurice Perol

Authors

M. Perol

Author affiliations

  • Centre Léon Bérard, Lyon/FR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

The scientific basis of TTFields

Presenter: Rami El Shafie

Session: Novocure GmbH - Tumor treating fields therapy: A force for change in lung cancer

Resources:

Webcast

The future of TTFields therapy in NSCLC

Presenter: Giovanni Luca Ceresoli

Session: Novocure GmbH - Tumor treating fields therapy: A force for change in lung cancer

Resources:

Webcast

Panel discussion

Session: Novocure GmbH - Tumor treating fields therapy: A force for change in lung cancer

Resources:

Webcast

Closing remarks

Presenter: Maurice Perol

Session: Novocure GmbH - Tumor treating fields therapy: A force for change in lung cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.